CN116035992A - Composition with functions of growing and fixing hair, preparation method and application - Google Patents
Composition with functions of growing and fixing hair, preparation method and application Download PDFInfo
- Publication number
- CN116035992A CN116035992A CN202310078305.3A CN202310078305A CN116035992A CN 116035992 A CN116035992 A CN 116035992A CN 202310078305 A CN202310078305 A CN 202310078305A CN 116035992 A CN116035992 A CN 116035992A
- Authority
- CN
- China
- Prior art keywords
- hair
- parts
- composition
- weight
- hair growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 78
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 239000002994 raw material Substances 0.000 claims abstract description 47
- 239000000843 powder Substances 0.000 claims abstract description 22
- 239000003623 enhancer Substances 0.000 claims abstract description 13
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- 235000016709 nutrition Nutrition 0.000 claims abstract description 9
- 230000035764 nutrition Effects 0.000 claims abstract description 9
- 239000000796 flavoring agent Substances 0.000 claims abstract description 8
- 235000013355 food flavoring agent Nutrition 0.000 claims abstract description 8
- 235000002378 plant sterols Nutrition 0.000 claims abstract description 8
- 229940059453 millet extract Drugs 0.000 claims abstract description 7
- 150000002148 esters Chemical class 0.000 claims abstract description 5
- 230000003779 hair growth Effects 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 27
- 238000002156 mixing Methods 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 15
- 238000007873 sieving Methods 0.000 claims description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 13
- 102000008186 Collagen Human genes 0.000 claims description 11
- 108010035532 Collagen Proteins 0.000 claims description 11
- 229920001436 collagen Polymers 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 10
- 238000005728 strengthening Methods 0.000 claims description 10
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 10
- 230000001737 promoting effect Effects 0.000 claims description 9
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 5
- 230000001070 adhesive effect Effects 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 210000000582 semen Anatomy 0.000 claims description 5
- 229960003080 taurine Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 claims description 4
- 239000011773 ferrous fumarate Substances 0.000 claims description 4
- 229960000225 ferrous fumarate Drugs 0.000 claims description 4
- 235000002332 ferrous fumarate Nutrition 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- -1 β -sitosterol ester Chemical class 0.000 claims description 3
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- 239000004386 Erythritol Substances 0.000 claims description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 2
- 229940076810 beta sitosterol Drugs 0.000 claims description 2
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 2
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims description 2
- 229940009714 erythritol Drugs 0.000 claims description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 2
- 235000019414 erythritol Nutrition 0.000 claims description 2
- 229950005143 sitosterol Drugs 0.000 claims description 2
- 150000003384 small molecules Chemical class 0.000 claims description 2
- 210000003780 hair follicle Anatomy 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 21
- 240000000249 Morus alba Species 0.000 abstract description 7
- 235000008708 Morus alba Nutrition 0.000 abstract description 7
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 210000004761 scalp Anatomy 0.000 abstract description 5
- 240000005662 Aronia melanocarpa Species 0.000 abstract description 4
- 235000007425 Aronia melanocarpa Nutrition 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 4
- 210000000442 hair follicle cell Anatomy 0.000 abstract description 4
- 230000000284 resting effect Effects 0.000 abstract description 4
- 230000035755 proliferation Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 230000003658 preventing hair loss Effects 0.000 abstract description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 59
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 52
- 241000699670 Mus sp. Species 0.000 description 45
- 241000699666 Mus <mouse, genus> Species 0.000 description 43
- 239000000523 sample Substances 0.000 description 36
- 239000013642 negative control Substances 0.000 description 22
- 201000004384 Alopecia Diseases 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 208000024963 hair loss Diseases 0.000 description 15
- 230000003676 hair loss Effects 0.000 description 14
- 230000000052 comparative effect Effects 0.000 description 13
- 239000013641 positive control Substances 0.000 description 12
- 230000008859 change Effects 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 5
- 231100000360 alopecia Toxicity 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 230000003698 anagen phase Effects 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- 230000002028 premature Effects 0.000 description 3
- 230000003405 preventing effect Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 2
- 244000062793 Sorghum vulgare Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 229930003756 Vitamin B7 Natural products 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000007717 exclusion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 2
- 229960004039 finasteride Drugs 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 235000019713 millet Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 238000000643 oven drying Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 229920002414 procyanidin Polymers 0.000 description 2
- 208000020016 psychiatric disease Diseases 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000003797 telogen phase Effects 0.000 description 2
- 235000011912 vitamin B7 Nutrition 0.000 description 2
- 239000011735 vitamin B7 Substances 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229940030486 androgens Drugs 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000031774 hair cycle Effects 0.000 description 1
- 230000034756 hair follicle development Effects 0.000 description 1
- 230000003661 hair follicle regeneration Effects 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229940075999 phytosterol ester Drugs 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000008470 skin growth Effects 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Inorganic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a composition with functions of growing and fixing hair, a preparation method and application, and belongs to the technical field of growing and fixing hair. The composition comprises the following raw materials in parts by weight: the main components comprise 1020 to 3050 parts of protein and 22.4 to 140 parts of nutrition enhancer; the functional components comprise 20-200 parts of powdered plant sterol ester, 100-500 parts of millet extract, 100-500 parts of rhizoma polygonati powder, 100-400 parts of mulberry powder and 100-500 parts of Aronia melanocarpa fruit powder; auxiliary ingredients, including 200-1800 parts of flavoring agent. The composition has no toxic or side effect, can promote metabolism and proliferation of hair follicle cells, can effectively promote formation of hair follicle melanin, shortens the time of hair follicle entering into growing period from resting period and growing hair, and can strengthen the tightness of hair in scalp, thereby achieving the effects of preventing hair loss and fixing hair.
Description
Technical Field
The invention belongs to the technical field of hair growth and hair fixation, and particularly relates to a composition with hair growth and hair fixation functions, a preparation method and application.
Background
Statistics show that alopecia has become increasingly prevalent and a trend towards low age.
Products with functions of growing and fixing hair are declared to be more in the market, but the products are not ideal in the aspect of growing and fixing hair; most hair-growing products are washing and caring products, and other products are few, however, the washing and caring products are required to have a cleaning function, and chemical components such as a surfactant and a conditioner which can damage hair are inevitably added, so that a composition with good hair-growing and hair-fixing effects is needed.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides a composition with functions of generating and fixing hair, a preparation method and application.
In order to achieve the above purpose, the present invention provides the following technical solutions:
one of the technical schemes of the invention is as follows: the composition with the hair growth and fixation functions comprises the following raw materials in parts by weight:
further, the proteins include small molecule peptides and amino acids; the small molecular peptide comprises 500-1500 parts by weight of bovine bone collagen peptide and 500-1500 parts by weight of hydrolyzed collagen peptide; the amino acid comprises 20-50 parts of taurine in parts by weight.
Further, the nutrition enhancer is a vitamin enhancer and a mineral enhancer.
Further, the vitamin reinforcer comprises 0.2 to 10 parts of vitamin A, 10 to 50 parts of vitamin C, 1 to 10 parts of vitamin E and 10 to 50 parts of yeast powder in parts by weight; the mineral fortifier comprises, by weight, 1-10 parts of ferrous fumarate and 0.2-10 parts of zinc oxide.
Further, the powdered plant sterol ester is beta-sitosterol ester with a chemical formula of C 47 O 2 H 80 。
Further, the preparation method of the millet extract comprises the following steps: pulverizing semen Setariae, extracting with water, concentrating the extractive solution, and lyophilizing to obtain semen Setariae extract.
Further, the flavoring agent comprises 100-500 parts by weight of erythritol and 100-500 parts by weight of grapefruit powder.
The second technical scheme of the invention is as follows: the preparation method of the composition with the hair growth and fixation functions comprises the following steps:
(1) Weighing the raw materials according to the weight parts, and sieving for standby;
(2) Mixing the nutrition enhancer and the flavoring agent weighed in the step (1) to obtain a mixed raw material A;
(3) Placing the protein and the functional components weighed in the step (1) into a granulator for stirring, granulating by taking alcohol as an adhesive, drying by a fluidized bed, and granulating by a granulator to obtain a mixed raw material B;
(4) And (3) mixing the mixed raw material A obtained in the step (2) with the mixed raw material B obtained in the step (3), and sieving to obtain the composition with the hair growth and hair strengthening functions.
Further, in the step (1), the sieving is performed by a 40-100 mesh sieve.
Further, in step (2), the mixing is an equal incremental mixing.
Further, in the step (3), the stirring revolution is 200-500 revolutions per minute; the alcohol consumption is 280-480 parts by mass of 70-95% alcohol sprayed within 2-10 min; the drying temperature of the fluidized bed is 51-58 ℃ and the drying time is 25-35 min; the granulator is a 20-mesh granulator.
Further, in the step (4), the sieving is performed by a 40-100 mesh sieve.
The third technical scheme of the invention: the composition with the functions of promoting hair growth and fixing hair is applied to the aspects of promoting hair growth and fixing hair.
Compared with the prior art, the invention has the following beneficial effects:
(1) The composition with the functions of growing and fixing hair prepared by the invention can shorten the time of hair follicle from resting stage to growing stage, can accelerate the time of growing hair, and has remarkable promoting effect on hair growth;
(2) The composition with the functions of generating and fixing hair prepared by the invention has no toxic or side effect, and can effectively promote hair follicle regeneration;
(3) The invention adopts the fluidized bed granulation instead of the oven drying, and has the advantages of relatively oven drying, uniform flow state, even drying, less damage to the surface of the material and more loose powder; the heat efficiency is high, the energy-saving effect is good, and the energy can be saved by 30 to 60 percent compared with the drying of an oven.
The added hydrolyzed collagen peptide belongs to a necessary composition substance of human skin, can effectively ensure skin moisture, increase skin firmness, and the most main protein in hair is keratin, so that the collagen can support and increase in-vivo hair growth proteins. This can help strengthen the hair, promote hair growth, and prevent hair loss;
in addition, the two collagen peptides are selected because one collagen peptide is extracted from animal skin, and the other collagen peptide is derived from bone, and the amino acid components and peptide fragments are different and can be mutually complemented;
the taurine added by the invention not only has the effect of repairing damaged hair, but also has the effects of increasing the generation of hair growth factors and promoting hair growth. Taurine increases the production of the growth factor IGF-1, which acts on the human hair cycle, lengthens the anagen phase, and produces thicker and stronger hair;
the added multivitamins can increase scalp nutrition, promote hair follicle cell metabolism and further promote hair growth;
the added yeast powder contains vitamin H and nicotinic acid, wherein the vitamin H is also called biotin, is a necessary nutrient for maintaining natural growth and development of a human body and normal human body functional health, can directly regulate and control metabolism of hair follicle cells, and can also indirectly influence hair follicle development by influencing feed intake or metabolism;
in addition, the nicotinic acid contained in the yeast powder is also an indispensable nutrient component in human body, plays an important role in promoting the normal growth and development of the human body, can promote iron absorption and the generation of blood cells, and maintains the normal function of skin;
ferrous fumarate is added, and the iron element provides oxygen for each cell of the body, including cells in scalp and hair follicles;
the zinc oxide is added, and zinc is an auxiliary factor of various enzymes in the body or an important component of antioxidant enzymes in the body, so that the activity of blood cells can be enhanced, and the zinc oxide is a trace element necessary for hair growth and keratin synthesis;
the powdered plant sterol ester added by the invention is prepared from plant sterol and fatty acid through esterification reaction or transesterification reaction. Sterol esters are capable of being converted to sterols and fatty acids in the human body, so their physiological functions include those possessed by both plant sterols and fatty acids. The plant sterol ester is easier to be absorbed by human body, the use efficiency is far higher than that of common plant sterols, and the alopecia can be prevented by inhibiting the generation of androgens;
the millet extract added by the invention is a rare oil extracted from millet, in particular to a millet extract (chemical formula: C) 31 H 52 O), the rare oil acts on the root of hair follicle, can accelerate the metabolism and proliferation of cells, keep the hair growing, nourish and repair damaged scalp, create good basic conditions for healthy hair, and have anti-inflammatory and anti-toxic effects;
the added rhizoma polygonati powder has the effects of returning kidney meridian, benefiting essence and filling marrow, and has good effects of treating kidney deficiency type alopecia and the like;
the mulberry powder added by the invention has the effects of tonifying kidney and replenishing essence and Wu Fasheng hair, and is suitable for the symptoms of premature senility, premature graying of beard and hair, hair loss, alopecia areata and hair withering; mulberry is a material in a medicine and food homologous catalog, and has the effect of treating premature graying of beard and hair according to pharmacopoeia records; mulberry is rich in procyanidins, and procyanidins can induce telogen hair follicle conversion to anagen phase by activating stem cells of hair follicle Long Tubu, so as to promote hair regeneration;
the Aronia melanocarpa fruit powder added by the invention is rich in various vitamins, antioxidant components and mineral elements, and has the effect of improving the blood circulation of the head.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings that are needed in the embodiments will be briefly described below, and it is obvious that the drawings in the following description are only some embodiments of the present invention, and other drawings may be obtained according to these drawings without inventive effort for a person skilled in the art.
FIG. 1 is a graph showing the change in back hair of mice to which sample 3# was administered;
FIG. 2 is a graph showing the change in back hair of mice dosed with low dose samples;
FIG. 3 is a graph showing the change in back hair of mice dosed with high doses of the samples;
FIG. 4 is a graph showing the change in back hair of mice dosed with positive control samples;
FIG. 5 is a graph showing the change in back hair of mice dosed with a negative control sample;
FIG. 6 is a statistical plot of the number of microscopic new hair follicles for dosing sample 3#, low dose sample, high dose sample, positive control sample, and negative control sample;
FIG. 7 shows HE staining patterns of the administered sample 3#, wherein (a) shows HE staining patterns of 7-day mouse skin histology, (b) shows HE staining patterns of 14-day mouse skin histology, (c) shows HE staining patterns of 28-day mouse skin histology, and (d) shows HE staining patterns of 56-day mouse skin histology;
FIG. 8 is a graph of HE staining of a low dose sample administered, wherein (a) is a graph of HE staining of 7 day mouse skin histology, (b) is a graph of HE staining of 14 day mouse skin histology, (c) is a graph of HE staining of 28 day mouse skin histology, and (d) is a graph of HE staining of 56 day mouse skin histology;
FIG. 9 is a graph of HE staining of a high dose sample administered, wherein (a) is a graph of HE staining of 7 day mouse skin histology, (b) is a graph of HE staining of 14 day mouse skin histology, (c) is a graph of HE staining of 28 day mouse skin histology, and (d) is a graph of HE staining of 56 day mouse skin histology;
FIG. 10 is a graph of HE staining of a positive control sample administered, wherein (a) is a graph of HE staining of 7-day mouse skin histology, (b) is a graph of HE staining of 14-day mouse skin histology, (c) is a graph of HE staining of 28-day mouse skin histology, and (d) is a graph of HE staining of 56-day mouse skin histology;
FIG. 11 is a graph of HE staining of a negative control sample administered, wherein (a) is a graph of HE staining of 7-day mouse skin histology, (b) is a graph of HE staining of 14-day mouse skin histology, (c) is a graph of HE staining of 28-day mouse skin histology, and (d) is a graph of HE staining of 56-day mouse skin histology.
Detailed Description
Various exemplary embodiments of the invention will now be described in detail, which should not be considered as limiting the invention, but rather as more detailed descriptions of certain aspects, features and embodiments of the invention. It is to be understood that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention.
In addition, for numerical ranges in this disclosure, it is understood that each intermediate value between the upper and lower limits of the ranges is also specifically disclosed. Every smaller range between any stated value or stated range, and any other stated value or intermediate value within the stated range, is also encompassed within the invention. The upper and lower limits of these smaller ranges may independently be included or excluded in the range.
Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although only preferred methods and materials are described herein, any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference for the purpose of disclosing and describing the methods and/or materials associated with the documents. In case of conflict with any incorporated document, the present specification will control.
It will be apparent to those skilled in the art that various modifications and variations can be made in the specific embodiments of the invention described herein without departing from the scope or spirit of the invention. Other embodiments will be apparent to those skilled in the art from consideration of the specification of the present invention. The specification and examples of the present invention are exemplary only.
As used herein, the terms "comprising," "including," "having," "containing," and the like are intended to be inclusive and mean an inclusion, but not limited to.
The parts in the embodiments of the present invention are parts by weight unless otherwise specified.
In the following examples, the powdered phytosterol esters were prepared according to patent CN 201410445798.0;
in the following examples, the preparation method of the millet extract comprises the following steps:
1) Drying semen Setariae in a hot air drying oven at 37deg.C for 24 hr, pulverizing, and sieving with 80 mesh sieve;
2) Vortex extracting the millet sieved in the step 1) with water at 50 ℃ for 1h according to the feed-liquid ratio of 1:10, filtering, repeating for two times, and respectively collecting filtrate and filter residues;
3) Concentrating the filtrate obtained in the step 2) until the solid content is 25-35% to obtain a concentrated solution;
4) Freeze-drying the concentrated solution obtained in the step 3) to obtain the millet extract, wherein the parameters of freeze-drying are that the water content is kept below 6%;
the mulberry powder, the Aronia melanocarpa fruit powder and the rhizoma polygonati powder are commercially available in the following examples, wherein the content of procyanidine in the mulberry powder, the Aronia melanocarpa fruit powder is 10%, and the content of yellow extract polysaccharide in the rhizoma polygonati powder is 15%;
the bovine collagen peptide and the hydrolyzed collagen peptide in the following examples are commercially available, and are food raw materials, and the protein content is 95%;
the vitamin A in the following examples is commercially available and is a food grade additive with an active substance content of 32.5 ten thousand IU/g;
the vitamin C in the following examples is commercially available as a food grade additive with an active substance content of 97%;
the taurine and ferrous fumarate in the following examples are commercially available and are food grade additives, and the content of effective substances is 99%;
the vitamin E in the following examples is commercially available and is a food grade additive, and the content of the active ingredients is 50%;
the yeast powder described in the following examples is commercially available, and the active substance niacin content is 40mg/g and biotin content is 300ppm.
In the following examples, the term "equal incremental mixing" refers to: the equal amount is increased to the raw material with the least dosage and the other raw material with the equal amount, the raw materials are uniformly mixed, then the other raw materials with the equal amount after the mixing are added, and the mixing of all the raw materials is completed.
Example 1
(1) Weighing the raw materials according to the weight parts described in the 1# in the table 1, and sieving the raw materials with a 40-mesh sieve for standby;
(2) Incrementally mixing the nutrition enhancer and the flavoring agent weighed in the step (1) in equal amount to obtain a mixed raw material A;
(3) Placing the protein and the functional components weighed in the step (1) into a granulator for stirring, granulating by taking alcohol as an adhesive, drying by a fluidized bed, and granulating by a 20-mesh granulator to obtain a mixed raw material B, wherein the stirring speed is 200 revolutions per minute, the alcohol consumption is 280 parts of 70% alcohol sprayed within 2 minutes, the drying temperature of the fluidized bed is 51 ℃, and the time is 25 minutes;
(4) Mixing the mixed raw material A obtained in the step (2) with the mixed raw material B obtained in the step (3), and sieving with a 40-mesh sieve to obtain the composition with the functions of generating and fixing hair.
Example 2
(1) Weighing the raw materials according to the weight parts described in the No. 2 in the table 1, and sieving the raw materials with a 100-mesh sieve for standby;
(2) Incrementally mixing the nutrition enhancer and the flavoring agent weighed in the step (1) in equal amount to obtain a mixed raw material A;
(3) Placing the protein and the functional components weighed in the step (1) into a granulator for stirring, granulating by taking alcohol as an adhesive, drying by a fluidized bed, and granulating by a 20-mesh granulator to obtain a mixed raw material B, wherein the stirring speed is 500 revolutions per minute, 480 parts of 95% alcohol is sprayed within 10 minutes, and the drying temperature of the fluidized bed is 58 ℃ for 35 minutes;
(4) Mixing the mixed raw material A obtained in the step (2) with the mixed raw material B obtained in the step (3), and sieving with a 100-mesh sieve to obtain the composition with the functions of generating and fixing hair.
Example 3
(1) Weighing the raw materials according to the weight parts described in 3# in table 1, and sieving with a 60-mesh sieve for standby;
(2) Incrementally mixing the nutrition enhancer and the flavoring agent weighed in the step (1) in equal amount to obtain a mixed raw material A;
(3) Placing the protein and the functional components weighed in the step (1) into a granulator for stirring, granulating by taking alcohol as an adhesive, drying by a fluidized bed, and granulating by a 20-mesh granulator to obtain a mixed raw material B, wherein the stirring speed is 350 r/min, 300 parts of 85% alcohol is sprayed within 5.5min, and the drying temperature of the fluidized bed is 55 ℃ for 30min;
(4) Mixing the mixed raw material A obtained in the step (2) with the mixed raw material B obtained in the step (3), and sieving with a 60-mesh sieve to obtain the composition with the functions of generating and fixing hair.
Table 1 amounts of raw materials
Comparative example 1
The procedure of example 3 was repeated except that the raw materials were weighed in the parts by weight shown in Table 2, and sieved through a 60-mesh sieve in step (1).
Comparative example 2
The difference in the procedure of example 3 is that the raw materials are weighed in the parts by weight shown in Table 2# 5 and sieved with a 60 mesh sieve for use in the procedure of step (1).
Comparative example 3
The difference in the procedure of example 3 is that the raw materials in the step (1) are weighed in the parts by weight shown in Table 2# 6 and sieved with a 60 mesh sieve for use.
Comparative example 4
The procedure of example 3 was repeated except that the raw materials were weighed in the parts by weight shown in Table 2 No. 7 in step (1), and sieved with a 60-mesh sieve.
Comparative example 5
The difference in the procedure of example 3 is that the raw materials in the step (1) are weighed in parts by weight as shown in Table 2# 8 and sieved with a 60 mesh sieve for use.
Comparative example 6
The difference in the procedure of example 3 is that the raw materials in the step (1) are weighed according to the parts by weight shown in 9# in Table 2 and sieved with a 60 mesh sieve for use.
Comparative example 7
The same procedure as in example 3 was repeated except that the raw materials were weighed in the parts by weight shown in Table 2 at 10# and sieved through a 60 mesh sieve for use in step (1).
Comparative example 8
The procedure of example 3 was repeated except that the raw materials were weighed in the parts by weight shown in 11# in Table 2 in step (1), and sieved with a 60-mesh sieve.
Comparative example 9
The difference in the procedure of example 3 is that the raw materials are weighed in the parts by weight shown in Table 2# 12 and sieved with a 60 mesh sieve for use in the procedure of step (1).
Comparative example 10
The difference is that the black bean powder is used to replace the mulberry powder in the step (1) as in example 3.
TABLE 2 amounts of raw materials
Effect verification
1. Prescription effect verification
Selection of (one) subject
Selecting qualified subjects according to the inclusion and exclusion criteria;
1. criteria for inclusion
(1) 25-45 years old, healthy men or women;
the length of the hair is between 5 and 40 cm;
(2) The hair loss is excessive and the hair is slightly sparse, and the hair loss count is more than 10 according to a 60-time comb method, and the hair loss count is still more than 10 after a 2-week preparation period;
(3) No special hair-dressing treatment such as hair dyeing, hair waving and shaping is performed within 1 month;
2. exclusion criteria
(1) Pregnant or lactating women, or those who have a pregnancy preparation plan recently;
(2) Patients suffering from mental or psychological disorders; or with long-term sleep, mood control disorders;
(3) Cosmetic with hair loss preventing effect or other products with such effect or hair growth promoting effect are used in about 3 months;
(4) Any drugs affecting hair growth are taken or topically applied in the last 6 months;
3. subject restriction
(1) During the screening and testing period of the subjects, the hair cannot be washed within 48+/-4 hours before each visit, the time of not washing the hair before each visit is basically consistent, and the hair cannot be combed by oneself on the day of the visit;
(2) No haircut was performed during the trial period for 2 weeks prior to each visit assessment;
(3) During the test, any hair care and hairdressing treatment measures cannot be performed, and any treatments for preventing alopecia and generating hair cannot be accepted;
(4) The original living habit is required to be kept during the test, so that the large emotion fluctuation is avoided;
(II) test substance
Test sample: the compositions prepared in examples 1 to 3 and comparative examples 1 to 9;
the using method comprises the following steps: randomly distributing test samples to the test subjects, and guiding the sample use of the test subjects to ensure that the test subjects correctly use the test objects in a test period, wherein the test objects are used for 12 weeks, and the test subjects are required to record the use time and any discomfort and adverse reaction symptoms in the use process during the test period;
(III) test Equipment
Comb: the comb teeth have moderate density (the tooth space is 0.9-1.1 mm), the length of the comb teeth is 2.0-3.0 cm, the length of the comb is not less than 10cm (no comb handle is contained), the comb with the same specification and material is required to be used in the whole test process, and the related requirements in the medical institution disinfection technical Specification (WS-T367-2012) are referred to for disinfection after each use;
(IV) test procedure
Subjects were recruited as required, and the number of hair loss was counted and recorded using 60 comb hair treatments;
qualified subjects underwent a 2-week preparation period using 0.9% sodium chloride solution; after the preparation period is finished, performing a hair combing method for 60 times again, and entering a formal test for the people with the hair loss count still greater than 10;
subjects enrolled in the formal trial were grouped into 12 groups according to a hierarchical randomization method, ensuring that factors that might affect the outcome of the trial, for example: balance of sex, age, hair length, severity of hair loss, etc.;
performing evaluation of hair base values prior to product use, including hair loss count, record; the same evaluation and test was again performed after 4 weeks, 8 weeks, 12 weeks after the use of the product;
(V) alopecia count: subjects were combed with their hair by a trained staff member at each visit using a 60-pass combing method, the hair loss counted, and recorded.
(sixth) test results
The result of verification of the prescription effect is shown in table 3;
table 3 results of prescription Effect verification
(seventh) conclusion
As can be seen from the data of table 3, the difference in the hair loss count after 12 weeks (hair loss count before product use-hair loss count after 12 weeks of product use) of examples 1 to 3 was higher than that of comparative examples 1 to 10, and therefore, the hair loss preventing efficacy of examples 1 to 3 was better than that of comparative examples 1 to 10; in examples 1 to 3, the anti-hair loss effect of example 3 was superior to examples 1 and 2.
2. Dose effect verification
Experimental materials and methods
1. Grouping mice:
50C 57BL/6J mice (SPF grade) with the age of 38-40 d and the weight of 15-20 g (provided by experimental animal center of southern medical university) are randomly divided into 5 groups after 3 days of adaptive feeding, 10 mice in each group are shaved at 24 hours before dosing, and the hair of the back of the mice is induced to enter the growing period from the resting period;
2. sample configuration:
1.54g of the composition prepared in example 3 was completely dissolved in 20mL of water to obtain sample # 3;
0.77g of the composition prepared in example 3 was completely dissolved in 20mL of water to obtain a low dose sample;
3.08g of the composition prepared in example 3 was completely dissolved in 20mL of water to obtain a high dose sample;
preparing finasteride solid into a finasteride solution with the concentration of 0.2%, so as to obtain a positive control sample;
preparing sodium chloride solid into 0.9% sodium chloride solution to obtain a negative control sample;
3. administration of drugs
(II) results of experiments
1. Weight change in mice
The body weight of the mice is weighed and recorded every 7d in the detection process, the average value is expressed as a mean value plus or minus standard deviation, and the specific results are shown in table 4;
TABLE 4 weight variation of mice (Unit: g)
From the above table data, it can be found that the body weight change trend of the 5 groups of mice is basically consistent in the whole detection process, and the mice have no abnormality.
2. Time required for skin changes and hair growth in mice
The skin and hair growth conditions of the dehairing areas of each group of mice were observed every day, the specific hair growth conditions are shown in fig. 1 to 5 (shooting is performed every 7 d), the time for changing the skin color of each mouse dehairing area from pink to black and the time for starting growing hair are recorded, the average value is expressed as a mean value + -standard deviation, and the specific results are shown in table 5;
FIG. 1 is a graph showing the change in back hair of mice to which sample 3# was administered;
FIG. 2 is a graph showing the change in back hair of mice dosed with low dose samples;
FIG. 3 is a graph showing the change in back hair of mice dosed with high doses of the samples;
FIG. 4 is a graph showing the change in back hair of mice dosed with positive control samples;
FIG. 5 is a graph showing the change in back hair of mice dosed with a negative control sample;
from the above graph, sample 3# showed that 2 mice had grayed skin and 2 mice had grown hair in D14, and 4 mice were found to have significantly grown hair in D21, with 1 mouse having hair grown in the 60% area of the back and 3 mice having all grown back;
the low dose samples showed greying of the skin of 1 mouse at D14 and found 5 mice growing hair at D21, 2 mice growing hair in the 70% area of the back and 2 mice growing hair in the 80% area of the back;
the high dose samples showed 5 hair growth on the backs of the 5 mice in D14 and 5 mice on D21, with 3 mice on 90% of the back and 2 mice on the whole;
the positive control samples showed 4 mice with greying skin, one with a pronounced hair growth on D14 and 6 mice with a 90% area on the back were found to have hair growth on D21.
The negative control samples showed graying of the skin in 2 mice at D14, 3 mice with hair growth in the 70% area of the back and 2 mice with hair growth in the 90% area of the back were found at D21.
TABLE 5 skin changes and time required for growing hair in mice (unit: d)
From the above table data, it can be seen that sample 3#, high dose sample, and positive control sample shortened the time to enter the anagen phase and grow hair to a different extent than the negative control sample; among them, sample 3# more significantly shortens the time for the hair follicle to enter anagen phase from telogen phase and grow out of hair.
3 Back skin histological examination of mice
Humane sacrifice after 24h of administration on day 7, day 14, day 28, day 56, 2 per sacrifice, skin specimens were taken at the same site in the shaved area, fixed, conventional flaking, HE staining, and the number of microscopic new hair follicles expressed as an average, with specific results shown in tables 6-9 and fig. 6;
table 67 skin histology index (Unit: personal) of mice
Table 7 skin histology index (Unit: personal) of 14 day mice
Table 8 skin histology index (Unit: personal) of mice over 28 days
Table 9 skin histology index (Unit: personal) of 56 days mice
HE staining patterns of sample 3#, low dose sample, high dose sample, positive control sample, and negative control sample are shown in fig. 7 to 11:
FIG. 7 is a graph of HE staining of sample 3# wherein (a) is a graph of HE staining of 7 day mouse skin histology, (b) is a graph of HE staining of 14 day mouse skin histology, (c) is a graph of HE staining of 28 day mouse skin histology, and (d) is a graph of HE staining of 56 day mouse skin histology;
FIG. 8 is a plot of HE staining of low dose samples, wherein (a) is a plot of HE staining of 7 day mouse skin histology, (b) is a plot of HE staining of 14 day mouse skin histology, (c) is a plot of HE staining of 28 day mouse skin histology, and (d) is a plot of HE staining of 56 day mouse skin histology;
FIG. 9 is a plot of HE staining of high dose samples, wherein (a) is a plot of HE staining of 7 day mouse skin histology, (b) is a plot of HE staining of 14 day mouse skin histology, (c) is a plot of HE staining of 28 day mouse skin histology, and (d) is a plot of HE staining of 56 day mouse skin histology;
FIG. 10 is a graph of HE staining of positive control samples, wherein (a) is a graph of HE staining of 7-day mouse skin histology, (b) is a graph of HE staining of 14-day mouse skin histology, (c) is a graph of HE staining of 28-day mouse skin histology, and (d) is a graph of HE staining of 56-day mouse skin histology;
FIG. 11 is a graph of HE staining of a negative control sample, wherein (a) is a graph of HE staining of 7-day mouse skin histology, (b) is a graph of HE staining of 14-day mouse skin histology, (c) is a graph of HE staining of 28-day mouse skin histology, and (d) is a graph of HE staining of 56-day mouse skin histology.
As can be seen from figures 6 to 11,
the negative control group is found to be in a descending trend in the whole period of the experiment through the skin histological examination of the back of the mice, and the new hair follicle number reaches a peak value in the D7; whereas the number of new hair follicles in the 3# high dose group D14 reached a maximum value, to a number of new hair follicles in the D28 group of 0; the number D7 of the new hair follicles in the positive control group reaches a peak value, and the whole experimental process shows a descending trend.
The number of new hair follicles in the negative control group is lower than that in the 3# and positive control groups in both the D7 and the D14, and the number of new hair follicles in the D28 negative control group is 0;
the number of new hair follicles in the low dose group is basically consistent with that in the negative control group, and the number of new hair follicles in the D7 and D14 is higher than that in the 3# and negative control groups;
the number of new hair follicles of 3# is obviously more than that of the new hair follicles of D7, D14 and D28 than that of the negative control group, the number of new hair follicles of D7 is 48.40 percent higher than that of the negative control group, the number of new hair follicles of D14 reaches the peak value, and the number of new hair follicles of D14 is 218.00 percent higher than that of the negative control group;
the number of new hair follicles in the high dose group is higher than that in the negative control group in D7 and D14, the number of new hair follicles in the D7 is 19.36 percent higher than that in the negative control group, the number of new hair follicles in the D14 is 32.15 percent higher than that in the negative control group, and the number of new hair follicles in the D28 and the number of new hair follicles in the negative control group are both 0;
the positive control group D7 reached a peak value, and showed a downward trend after D14, and the number of new hair follicles in the D28 group and the number of new hair follicles in the negative control group were both 0.
In conclusion, the composition provided by the invention has no toxic or side effect, can promote metabolism and proliferation of hair follicle cells, promote hair follicle neogenesis, shorten the time of hair follicle from a resting stage to a growing stage, has a remarkable promoting effect on hair growth, and is beneficial to strengthening the tightness of hair in scalp, so that the purpose of preventing hair loss and fixing hair is achieved.
In the foregoing, the protection scope of the present invention is not limited to the preferred embodiments, and any person skilled in the art, within the scope of the present invention, should be covered by the protection scope of the present invention by equally replacing or changing the technical scheme and the inventive concept thereof.
Claims (10)
2. the composition having a hair growth and hair strengthening function according to claim 1, wherein the protein comprises a small molecule peptide and an amino acid; the small molecular peptide comprises 500-1500 parts by weight of bovine bone collagen peptide and 500-1500 parts by weight of hydrolyzed collagen peptide; the amino acid comprises 20-50 parts of taurine in parts by weight.
3. The composition having a hair growth promoting and hair strengthening function according to claim 1, wherein the nutrition enhancer is a vitamin-based enhancer and a mineral-based enhancer.
4. The composition with hair growth and hair strengthening function according to claim 3, wherein the vitamin enhancer comprises, by weight, 0.2-10 parts of vitamin A, 10-50 parts of vitamin C, 1-10 parts of vitamin E and 10-50 parts of yeast powder; the mineral fortifier comprises, by weight, 1-10 parts of ferrous fumarate and 0.2-10 parts of zinc oxide.
5. The composition having a hair growth and hair strengthening function according to claim 1, wherein the powdery plant sterol ester is β -sitosterol ester.
6. The composition with hair growth and hair strengthening function according to claim 1, wherein the millet extract is prepared by the following steps: pulverizing semen Setariae, extracting with water, concentrating the extractive solution, and lyophilizing to obtain semen Setariae extract.
7. The composition with hair growth and hair strengthening function according to claim 1, wherein the flavoring agent comprises, by weight, 500-1200 parts of erythritol and 300-600 parts of grapefruit powder.
8. A method for preparing the composition having the hair growth and hair fixing function according to any one of claims 1 to 7, comprising the steps of:
(1) Weighing the raw materials according to the weight parts, and sieving for standby;
(2) Mixing the nutrition enhancer and the flavoring agent weighed in the step (1) to obtain a mixed raw material A;
(3) Placing the protein and the functional components weighed in the step (1) into a granulator for stirring, granulating by taking alcohol as an adhesive, drying by a fluidized bed, and granulating by a granulator to obtain a mixed raw material B;
(4) And (3) mixing the mixed raw material A obtained in the step (2) with the mixed raw material B obtained in the step (3), and sieving to obtain the composition with the hair growth and hair strengthening functions.
9. The method according to claim 8, wherein in the step (1), the sieving is performed by a 40-100 mesh sieve; in the step (2), the mixing is equal incremental mixing; in the step (3), the stirring revolution is 200-500 revolutions per minute; the alcohol consumption is 280-480 parts by mass of 70-95% alcohol sprayed within 2-10 min; the drying temperature of the fluidized bed is 51-58 ℃ and the drying time is 25-35 min; the granulator is a 20-mesh granulator; in the step (4), the sieving is carried out by a sieve with 40-100 meshes.
10. Use of the composition having hair growth and hair-fixing function according to any one of claims 1 to 7 for hair growth and hair-fixing.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310078305.3A CN116035992A (en) | 2023-01-12 | 2023-01-12 | Composition with functions of growing and fixing hair, preparation method and application |
JP2023079729A JP2024099465A (en) | 2023-01-12 | 2023-05-12 | Composition having hair-growing and hair-restoring functions, and production method and application of the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310078305.3A CN116035992A (en) | 2023-01-12 | 2023-01-12 | Composition with functions of growing and fixing hair, preparation method and application |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116035992A true CN116035992A (en) | 2023-05-02 |
Family
ID=86124034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310078305.3A Pending CN116035992A (en) | 2023-01-12 | 2023-01-12 | Composition with functions of growing and fixing hair, preparation method and application |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP2024099465A (en) |
CN (1) | CN116035992A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116439371A (en) * | 2023-05-05 | 2023-07-18 | 上海荷幸健康科技有限公司 | Nutrient formula for helping hair growth and preparation process |
CN116508921A (en) * | 2023-05-19 | 2023-08-01 | 柏维力生物技术(安徽)股份有限公司 | Composition for supplementing nutrition, preventing hair loss and fixing hair |
CN116712374A (en) * | 2023-08-08 | 2023-09-08 | 广州善元堂健康科技股份有限公司 | High-stability alopecia-preventing composition and preparation method thereof |
CN117356710A (en) * | 2023-10-17 | 2024-01-09 | 拜斯特药业(广州)有限公司 | Composition with scalp anti-aging effect and oral product |
-
2023
- 2023-01-12 CN CN202310078305.3A patent/CN116035992A/en active Pending
- 2023-05-12 JP JP2023079729A patent/JP2024099465A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116439371A (en) * | 2023-05-05 | 2023-07-18 | 上海荷幸健康科技有限公司 | Nutrient formula for helping hair growth and preparation process |
CN116508921A (en) * | 2023-05-19 | 2023-08-01 | 柏维力生物技术(安徽)股份有限公司 | Composition for supplementing nutrition, preventing hair loss and fixing hair |
CN116712374A (en) * | 2023-08-08 | 2023-09-08 | 广州善元堂健康科技股份有限公司 | High-stability alopecia-preventing composition and preparation method thereof |
CN116712374B (en) * | 2023-08-08 | 2023-10-31 | 广州善元堂健康科技股份有限公司 | High-stability alopecia-preventing composition and preparation method thereof |
CN117356710A (en) * | 2023-10-17 | 2024-01-09 | 拜斯特药业(广州)有限公司 | Composition with scalp anti-aging effect and oral product |
Also Published As
Publication number | Publication date |
---|---|
JP2024099465A (en) | 2024-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116035992A (en) | Composition with functions of growing and fixing hair, preparation method and application | |
CN105106028B (en) | A kind of peptide composition for hair growth | |
CN109568169B (en) | Active polypeptide with hair growth effect | |
JP2009545584A (en) | Hair growth promoter and method for producing the same | |
CN115120547B (en) | Non-irritating hair repair composition and anti-hair-loss shampoo | |
CN112870333A (en) | Composition and preparation for improving alopecia and promoting hair growth of human, and preparation method and application thereof | |
KR100636846B1 (en) | Oriental hair restorer and the method of the same | |
CN112043640B (en) | Composition and application thereof in preparation of anti-glycosylation cosmetics | |
CN115590776A (en) | Hair-growing and hair-thickening essence composition and preparation method and application thereof | |
CN114432198A (en) | Hair-care essence and using method thereof | |
CN102113985B (en) | Shampoo product and preparation method thereof | |
KR100903283B1 (en) | Hair growing material which contains a deer antler ingredient and its manufacturing method | |
KR100664400B1 (en) | Composition for preventing the hair from falling out | |
KR20140069588A (en) | Cosmetic composition containing onion skin extracts and loquat leaf extracts for the acceleration of hair growth | |
KR20090049390A (en) | The manufacturing method of natural unfalling out of hair | |
KR20030062605A (en) | Hair growth compositions using natural fermentation extract of herbs | |
CN114848569A (en) | Formula and preparation method of hair loss prevention and hair nourishing product | |
CN116392422A (en) | Hair-growing and oil-controlling herbal composition and preparation method and application thereof | |
CN115887319A (en) | Skin-nourishing, hair-loss-preventing and hair-consolidating alpine plant composition, essence thereof and preparation method | |
CN114366687A (en) | Use of isophthalic acid for promoting hair growth | |
CN101485875A (en) | Medicament composing prescription for preventing and treating alopecia and preparation method thereof | |
CN115779051B (en) | Compound traditional Chinese medicine for preventing hair loss and growing hair and application thereof | |
JP2553906B2 (en) | Hair nourishment | |
US20240315954A1 (en) | Hair care composition and methods of preparing the same and preparing plant extracts | |
CN117959228B (en) | Anti-dandruff and anti-hair-loss shampoo containing natural plant components and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |